122 related articles for article (PubMed ID: 2842617)
1. cAMP analogs used to study low-Km, hormone-sensitive phosphodiesterase.
Beebe SJ; Beasley-Leach A; Corbin JD
Methods Enzymol; 1988; 159():531-40. PubMed ID: 2842617
[TBL] [Abstract][Full Text] [Related]
2. Discriminative insulin antagonism of stimulatory effects of various cAMP analogs on adipocyte lipolysis and hepatocyte glycogenolysis.
Beebe SJ; Redmon JB; Blackmore PF; Corbin JD
J Biol Chem; 1985 Dec; 260(29):15781-8. PubMed ID: 2999137
[TBL] [Abstract][Full Text] [Related]
3. Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand.
Degerman E; Belfrage P; Newman AH; Rice KC; Manganiello VC
J Biol Chem; 1987 Apr; 262(12):5797-807. PubMed ID: 3032944
[TBL] [Abstract][Full Text] [Related]
4. The identification and characterization of two cyclic nucleotide phosphodiesterases from bovine adrenal medulla.
Sabatine JM; Coffee CJ
Arch Biochem Biophys; 1986 Aug; 249(1):95-105. PubMed ID: 3017224
[TBL] [Abstract][Full Text] [Related]
5. Selective alteration of Ca2+-dependent and Ca2+-independent cyclic nucleotide phosphodiesterase activity in rat cerebral cortex by cyclic nucleotides and their analogs.
Davis CW
Biochim Biophys Acta; 1982 Jul; 705(1):1-7. PubMed ID: 6288105
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the kinetics of cyclic AMP hydrolysis by the cyclic GMP-stimulated cyclic nucleotide phosphodiesterase.
Wada H; Manganiello VC; Osborne JC
J Biol Chem; 1987 Oct; 262(29):13938-45. PubMed ID: 2820985
[TBL] [Abstract][Full Text] [Related]
7. Hormonal regulation of 3',5'-adenosine monophosphate phosphodiesterases in cultured rat granulosa cells.
Conti M; Kasson BG; Hsueh AJ
Endocrinology; 1984 Jun; 114(6):2361-8. PubMed ID: 6202500
[TBL] [Abstract][Full Text] [Related]
8. Insulin-sensitive cAMP phosphodiesterase in rat adipose tissue.
Kono T
Methods Enzymol; 1988; 159():745-51. PubMed ID: 2842637
[No Abstract] [Full Text] [Related]
9. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
Nemecek GM; Butcher RW
J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
[TBL] [Abstract][Full Text] [Related]
10. Effects of fatty acids on activity of cGMP-stimulated cyclic nucleotide phosphodiesterase from calf liver.
Yamamoto T; Yamamoto S; Manganiello VC; Vaughan M
Arch Biochem Biophys; 1984 Feb; 229(1):81-9. PubMed ID: 6322693
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a hormone-inducible, high affinity adenosine 3'-5'-cyclic monophosphate phosphodiesterase from the rat Sertoli cell.
Conti M; Iona S; Cuomo M; Swinnen JV; Odeh J; Svoboda ME
Biochemistry; 1995 Jun; 34(25):7979-87. PubMed ID: 7794911
[TBL] [Abstract][Full Text] [Related]
12. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
13. Purification, characterization and production of rabbit antibodies to rat liver particulate, high-affinity, cyclic AMP phosphodiesterase.
Whitson RH; Appleman MM
Biochim Biophys Acta; 1982 Feb; 714(2):279-91. PubMed ID: 6275911
[TBL] [Abstract][Full Text] [Related]
14. Two classes of cAMP analogs which are selective for the two different cAMP-binding sites of type II protein kinase demonstrate synergism when added together to intact adipocytes.
Beebe SJ; Holloway R; Rannels SR; Corbin JD
J Biol Chem; 1984 Mar; 259(6):3539-47. PubMed ID: 6323428
[TBL] [Abstract][Full Text] [Related]
15. cAMP analogs and selective inhibitors used to study low Km Mucor rouxii cAMP phosphodiesterase.
Tomes C; Moreno S
Int J Biochem; 1990; 22(9):1047-51. PubMed ID: 1704316
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of two soluble adenosine cyclic 3',5'-phosphate phosphodiesterases partially purified from calf liver.
Yamamoto T; Lieberman F; Osborne JC; Manganiello VC; Vaughan M; Hidaka H
Biochemistry; 1984 Feb; 23(4):670-5. PubMed ID: 6324851
[TBL] [Abstract][Full Text] [Related]
17. The antilipolytic effect of insulin does not require adenylate cyclase or phosphodiesterase action.
Gabbay RA; Lardy HA
FEBS Lett; 1985 Jan; 179(1):7-11. PubMed ID: 2981181
[TBL] [Abstract][Full Text] [Related]
18. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
19. Substrate specificity of cyclic nucleotide phosphodiesterase from beef heart and from Dictyostelium discoideum.
Van Haastert PJ; Dijkgraaf PA; Konijn TM; Abbad EG; Petridis G; Jastorff B
Eur J Biochem; 1983 Apr; 131(3):659-66. PubMed ID: 6301815
[TBL] [Abstract][Full Text] [Related]
20. Effect of adenosine 3',5'-cyclic monophosphate derivatives on alpha-amylase release, protein kinase and cyclic nucleotide phosphodiesterase activity from rat parotid tissue.
Butcher FR; Thayer M; Goldman JA
Biochim Biophys Acta; 1976 Feb; 421(2):289-95. PubMed ID: 175844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
